U.S., Liberia kick off trial of Ebola drug ZMapp

World / Science & Health Mar 2, 2015

U.S., Liberia kick off trial of Ebola drug ZMapp

U.S. and Liberian researchers have started a clinical trial to test the safety and effectiveness of Mapp Biopharmaceutical Inc.'s Ebola drug ZMapp, an experimental treatment that has already been tried in a handful of Ebola patients, including two U.S. missionaries. The trial, a joint effort ...

Experimental Ebola drugs needed for 'up to 30,000 people'

World / Science & Health Aug 21, 2014

Experimental Ebola drugs needed for 'up to 30,000 people'

Up to 30,000 people could have used experimental treatments or vaccines so far in the world's worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday. The calculation highlights the dilemma facing officials considering how to distribute the tiny quantities of unproven ...

Liberia gets Ebola drug, ponders who should get it

World Aug 14, 2014

Liberia gets Ebola drug, ponders who should get it

Liberia faced an excruciating choice Thursday: deciding which handful of Ebola patients will receive an experimental drug that could prove either life-saving or life-threatening. ZMapp, the untested Ebola drug, arrived in the West African country late Wednesday. Assistant Health Minister Tolbert Nyenswah said three or ...